Colistin plus meropenem combination is synergistic in vitro against extensively drug-resistant Pseudomonas aeruginosa, including high-risk clones

•Extensively drug resistant (XDR) Pseudomonas aeruginosa causes severe infections.•There is a high risk of resistance selection in these clones.•Colistin has been the only available treatment but that is not an optimal treatment.•Combination regimens could suppress emerging resistance.•Colistin plus...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of global antimicrobial resistance. 2019-09, Vol.18, p.37-44
Hauptverfasser:	Montero, María M., Domene Ochoa, Sandra, López-Causapé, Carla, VanScoy, Brian, Luque, Sonia, Sorlí, Luisa, Campillo, Núria, Padilla, Eduardo, Prim, Núria, Segura, Concepción, Pomar, Virginia, Rivera, Alba, Grau, Santiago, Ambrose, Paul G., Oliver, Antonio, Horcajada, Juan P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Colistin Combination therapy Meropenem Pseudomonas aeruginosa Synergy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!